Not a member? Sign up for free!

RASP: A Self-Report Tool For Relapse Risk In Patients Living With Schizophrenia

Community Voices | March 4, 2019

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU

Schizophrenia affects roughly 1.1% percent of the U.S. population (3.4 million adults), with direct annual costs estimated at $47 billion. Schizophrenia is defined as a chronic, relapsing, and disabling disorder, which may include symptomology such as hallucinations, delusions, disoriented-thinking, affective flattening, apathy, and social withdrawal. Relapse in schizophrenia can occur when patients don’t adhere to…

You must be logged in to read the full article: Join PsychU or Log In